We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Promethean | LSE:PTH | London | Ordinary Share | GB00B08H5G38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.125 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:9674H
PPL Therapeutics PLC
25 February 2003
PPL Therapeutics plc ("the Company")
DISCLOSURE OF INTEREST
The Company received notification on 24 February 2003 that Credit Suisse First
Boston (Europe) Limited no longer has a notifiable interest in the Ordinary
shares of 50p each in the Company.
Credit Suisse First Boston (Europe) Limited is a member of the Credit Suisse
First Boston group of companies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVRBROARUUAR
1 Year Promethean Chart |
1 Month Promethean Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
